These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 39269960)

  • 1. The reproducibility and predictivity of radiomic features extracted from dynamic contrast-enhanced computed tomography of hepatocellular carcinoma.
    Ibrahim A; Guha S; Lu L; Geng P; Wu Q; Chou Y; Yang H; Wang D; Schwartz LH; Xie CM; Zhao B
    PLoS One; 2024; 19(9):e0310486. PubMed ID: 39269960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of inter-reader contouring variability on textural radiomics of colorectal liver metastases.
    Rizzetto F; Calderoni F; De Mattia C; Defeudis A; Giannini V; Mazzetti S; Vassallo L; Ghezzi S; Sartore-Bianchi A; Marsoni S; Siena S; Regge D; Torresin A; Vanzulli A
    Eur Radiol Exp; 2020 Nov; 4(1):62. PubMed ID: 33169295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiomic feature reproducibility in contrast-enhanced CT of the pancreas is affected by variabilities in scan parameters and manual segmentation.
    Yamashita R; Perrin T; Chakraborty J; Chou JF; Horvat N; Koszalka MA; Midya A; Gonen M; Allen P; Jarnagin WR; Simpson AL; Do RKG
    Eur Radiol; 2020 Jan; 30(1):195-205. PubMed ID: 31392481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improving radiomics reproducibility using deep learning-based image conversion of CT reconstruction algorithms in hepatocellular carcinoma patients.
    Lee H; Chang W; Kim HY; Sung P; Cho J; Lee YJ; Kim YH
    Eur Radiol; 2024 Mar; 34(3):2036-2047. PubMed ID: 37656175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Precision of MRI radiomics features in the liver and hepatocellular carcinoma.
    Carbonell G; Kennedy P; Bane O; Kirmani A; El Homsi M; Stocker D; Said D; Mukherjee P; Gevaert O; Lewis S; Hectors S; Taouli B
    Eur Radiol; 2022 Mar; 32(3):2030-2040. PubMed ID: 34564745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiomics machine-learning signature for diagnosis of hepatocellular carcinoma in cirrhotic patients with indeterminate liver nodules.
    Mokrane FZ; Lu L; Vavasseur A; Otal P; Peron JM; Luk L; Yang H; Ammari S; Saenger Y; Rousseau H; Zhao B; Schwartz LH; Dercle L
    Eur Radiol; 2020 Jan; 30(1):558-570. PubMed ID: 31444598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reproducibility and non-redundancy of radiomic features extracted from arterial phase CT scans in hepatocellular carcinoma patients: impact of tumor segmentation variability.
    Qiu Q; Duan J; Duan Z; Meng X; Ma C; Zhu J; Lu J; Liu T; Yin Y
    Quant Imaging Med Surg; 2019 Mar; 9(3):453-464. PubMed ID: 31032192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor attenuation and quantitative analysis of perfusion parameters derived from tri-phasic CT scans in hepatocellular carcinoma: Relationship with histological grade.
    Pang G; Shao C; Lv Y; Zhao F
    Medicine (Baltimore); 2021 Apr; 100(16):e25627. PubMed ID: 33879737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiomics model based on contrast-enhanced computed tomography imaging for early recurrence monitoring after radical resection of AFP-negative hepatocellular carcinoma.
    Yan X; Li Y; Qin W; Liao J; Fan J; Xie Y; Wang Z; Li S; Liao W
    BMC Cancer; 2024 Jun; 24(1):700. PubMed ID: 38849749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiomic analysis of contrast-enhanced CT predicts microvascular invasion and outcome in hepatocellular carcinoma.
    Xu X; Zhang HL; Liu QP; Sun SW; Zhang J; Zhu FP; Yang G; Yan X; Zhang YD; Liu XS
    J Hepatol; 2019 Jun; 70(6):1133-1144. PubMed ID: 30876945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Noninvasive identification of SOX9 status using radiomics signatures may help construct personalized treatment strategy in hepatocellular carcinoma.
    Che F; Wei Y; Xu Q; Li Q; Zhang T; Wang LY; Li M; Yuan F; Song B
    Abdom Radiol (NY); 2024 Sep; 49(9):3024-3035. PubMed ID: 38446180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiomic Features at Contrast-enhanced CT Predict Recurrence in Early Stage Hepatocellular Carcinoma: A Multi-Institutional Study.
    Ji GW; Zhu FP; Xu Q; Wang K; Wu MY; Tang WW; Li XC; Wang XH
    Radiology; 2020 Mar; 294(3):568-579. PubMed ID: 31934830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Using a single abdominal computed tomography image to differentiate five contrast-enhancement phases: A machine-learning algorithm for radiomics-based precision medicine.
    Dercle L; Ma J; Xie C; Chen AP; Wang D; Luk L; Revel-Mouroz P; Otal P; Peron JM; Rousseau H; Lu L; Schwartz LH; Mokrane FZ; Zhao B
    Eur J Radiol; 2020 Apr; 125():108850. PubMed ID: 32070870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatobiliary MR contrast agent uptake as a predictive biomarker of aggressive features on pathology and reduced recurrence-free survival in resectable hepatocellular carcinoma: comparison with dual-tracer 18F-FDG and 18F-FCH PET/CT.
    Mulé S; Chalaye J; Legou F; Tenenhaus A; Calderaro J; Galletto Pregliasco A; Laurent A; Kharrat R; Amaddeo G; Regnault H; Tacher V; Kobeiter H; Itti E; Luciani A
    Eur Radiol; 2020 Oct; 30(10):5348-5357. PubMed ID: 32405753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dynamic contrast-enhanced ultrasound (DCE-US) for easy and rapid evaluation of hepatocellular carcinoma compared to dynamic contrast-enhanced computed tomography (DCE-CT)--a pilot study.
    Egger C; Goertz RS; Strobel D; Lell M; Neurath MF; Knieling F; Scharf M
    Ultraschall Med; 2012 Dec; 33(6):587-92. PubMed ID: 23154871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utility of non-contrast-enhanced CT for improved detection of arterial phase hyperenhancement in hepatocellular carcinoma.
    Hennedige T; Yang ZJ; Ong CK; Venkatesh SK
    Abdom Imaging; 2014 Dec; 39(6):1247-54. PubMed ID: 24943135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiogenesis of hepatocellular carcinoma under multislice spiral CT plain scan and enhanced scan.
    Ma AD; Zhang Y; Xue Z; Li K
    J Biol Regul Homeost Agents; 2015; 29(4):895-903. PubMed ID: 26753654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiomic analysis based on magnetic resonance imaging for the prediction of VEGF expression in hepatocellular carcinoma patients.
    Yang C; Zhang ZM; Zhao ZP; Wang ZQ; Zheng J; Xiao HJ; Xu H; Liu H; Yang L
    Abdom Radiol (NY); 2024 Nov; 49(11):3824-3833. PubMed ID: 38896246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiomics analysis enables recurrence prediction for hepatocellular carcinoma after liver transplantation.
    Guo D; Gu D; Wang H; Wei J; Wang Z; Hao X; Ji Q; Cao S; Song Z; Jiang J; Shen Z; Tian J; Zheng H
    Eur J Radiol; 2019 Aug; 117():33-40. PubMed ID: 31307650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detecting hepatocellular carcinoma: value of unenhanced or arterial phase CT imaging or both used in conjunction with conventional portal venous phase contrast-enhanced CT imaging.
    Oliver JH; Baron RL; Federle MP; Rockette HE
    AJR Am J Roentgenol; 1996 Jul; 167(1):71-7. PubMed ID: 8659425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.